Intensity Therapeutics, Inc.INTSNASDAQ
Loading
Analyst Sentiment
Analysts lean bullish — 100% recommend buying.
Consensus Rating
Buy
3 analysts·Low coverage
100%
Rating Distribution
Strong Buy
00%
Buy
3100%
Hold
00%
Sell
00%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Current price is 34% above analyst consensus — significant downside expected.
Bear Case
$5.00
-34%
Consensus
$5.00
-34%
Bull Case
$5.00
+-34%
Price Range3 analysts
Low
Consensus
High
$5.00
$5.00
Current Target
Current Price
$7.52
Above Target
$2.52
Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.